Sensorimotor neurotoxicity associated with high-dose deferoxamine treatment Academic Article Article uri icon

Overview

MeSH Major

  • Anxiety
  • Depression
  • Thalassemia

abstract

  • These cases demonstrate that a reversible sensorimotor neurotoxicity, a previously unreported toxicity, may complicate DFO therapy, this complements the previously reported auditory and visual neurotoxicity associated with DFO therapy. Discontinuation of therapy at the time of onset of neurotoxicity is recommended, with possible resumption at lower doses.

publication date

  • March 1997

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/00043426-199703000-00008

PubMed ID

  • 9149744

Additional Document Info

start page

  • 139

end page

  • 41

volume

  • 19

number

  • 2